Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jennifer E Hibma (Jennifer Hibma)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Duchenne Muscular Dystrophy

Top Venues

CPT: pharmacometrics & systems pharmacology

Cancer chemotherapy and pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology (2023)
Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Jennifer E Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O Harnisch
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy. CPT: pharmacometrics & systems pharmacology 12 (3) (2023)
Jennifer E Hibma, Melissa O'Gorman, Sunil Nepal, Sylvester Pawlak, Katherine Ginman, Yazdi K Pithavala
Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants. Cancer chemotherapy and pharmacology (2021)
Jennifer E Hibma, Beverly Knight
Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia. Clinical pharmacokinetics 58 (3) (2020)